Investors

Our Investors

To achieve our ambitious strategy to become a leading biotech company in the development of single-strain keystone biotherapies, we are open to welcome new investors.

Established in 2010, YSOPIA Bioscience has already raised €22.7M.

> Discover our pipeline

Key facts:

We are backed by renowned and valuable investors.

Seventure Partners / Health For Life Capital, Europe’s leading microbiome innovation investment fund, is our historic lead investor.

Three family offices have also backed YSOPIA Bioscience, as well as public investors, including the Nouvelle Aquitaine region. We also received support from BPI France.

Want to talk to our CEO?

Microbiome & us
News
Jan 20, 2022
Alliance Promotion Microbiote devient une Association et poursuit la structuration de la filière française du...
> more
Dec 2, 2021
YSOPIA Bioscience Announces First Signs of Biological Activity from Phase I Analysis of Xla1, its Biotherapy Targeting...
> more
Press / Media
Dec 3, 2021
Access the full article  
> more
Dec 3, 2021
YSOPIA Bioscience annonce des premiers signes d’activité biologique suite à l’analyse des résultats de l’étude...
> more
Publications
Nov 1, 2021
We are pleased to present our poster highlighting safety and first efficacy results of our Xla1 biotherapy targeting...
> more
Sep 1, 2021
Héloïse Tudela, Sandrine P. Claus and Maya Saleh Access the full paper The community of the diverse microorganisms...
> more
now on twitter
YSOPIA Bioscience

On January 26th - 1,50pm, our CSO Sandrine Claus will be presenting the results of our latest research on Christens… t.co/FD0xMEojxr

YSOPIA Bioscience © 2022 - all rights reserved terms and conditions